ÜBER DIESE EPISODE
Gleb Kuznetsov talks about about ditching Google for grad school, what it takes to build a true platform company, and where AI-driven drug discovery is headed.
Englisch
Vereinigte Staaten
TRANSKRIPT 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
VERGANGENE FOLGEN SUCHEN
Vorhandene Folgen von Transcribed durchsuchen.
WEITERE EPISODEN IN DIESEM PODCAST
Sara Kenkare-Mitra talks about resilience, risk, and the kind of leadership it takes to save failing drug programs — and make medicines that matter.
(00:00) Introduction to Sara Kenkare-Mitra
(00:36) Turning a (nearly) failed program into a bestselling drug
(08:33) Learning from industry legends
(2…
Patrick Hsu reflects on the early days of CRISPR, the power of mentorship, and how AI and open science will reshape the future of research.
(00:00) Introduction to Patrick Hsu
(01:06) Realizing how big CRISPR would become
(06:20) Why Feng Zhang's lab is so high-impact
(14:23) How to spot a breakthr…
Karen Akinsanya unpacks the rise of computational drug discovery, what it takes to prove impact of new technologies, and the importance of setting realistic expectations for AI.
(00:00) Introduction to Karen Akinsanya
(01:54) Pursuing big technological shifts
(06:24) How computation is setting the …
Andrew Bellinger discusses what it takes to build new drug modalities from scratch, the bold bets and tough calls that shaped Verve’s journey, and lessons in building new companies from first-in-class science.
* Editor's note: The interview was recorded following the announcement of Verve's acquisi…
Jake Becraft reflects on making bold bets in mRNA, the journey from lab bench to biotech founder, and the state of science today.
(00:00) Introduction to Jake Becraft
(00:39) Betting big on mRNA — before it was a proven modality
(11:34) Getting your drugs to patients
(25:47) The state of modern bio…
Rechtliche Hinweise: Der auf dieser Seite eingebettete Podcast und das Bildmaterial stammen von Benchling, das Eigentum seines Eigentümers ist und nicht mit Listen Notes, Inc. verbunden ist oder von diesen unterstützt wird.
BEARBEITEN
Vielen Dank, dass Sie uns helfen, die Podcast-Datenbank auf dem neuesten Stand zu halten.
